Results 41 to 50 of about 66,822 (310)

Bisphosphonate-associated osteonecrosis of the jaw in rheumatology: a sistematic review

open access: yesReumatismo, 2011
Osteonecrosis of the jaw (ONJ) is a well-known devastating side effect of parenteral bisphosphonate therapy for cancer. Several ONJ cases have been reported in patients taking oral bisphosphonates for osteoporosis or Paget’s disease.
F. Capsoni
doaj   +1 more source

Cost-Effectiveness of Zoledronic Acid Versus Oral Alendronate for Postmenopausal Osteoporotic Women in China

open access: yesFrontiers in Pharmacology, 2020
ObjectiveThis study aims to estimate the cost-effectiveness of yearly intravenous zoledronic acid treatment versus weekly oral alendronate for postmenopausal osteoporotic women in China.MethodsWe used a Markov microsimulation model to compare the cost ...
Ruxu You   +8 more
doaj   +1 more source

Immobilized Bisphosphonates as Potential Inhibitors of Bioprosthetic Calcification: Effects on Various Xenogeneic Cardiovascular Tissues

open access: yesBiomedicines, 2021
Calcification is the major factor limiting the clinical use of bioprostheses. It may be prevented by the immobilization of bisphosphonic compounds (BPs) on the biomaterial.
Irina Y. Zhuravleva   +6 more
doaj   +1 more source

Carpal tunnel syndrome associated with oral bisphosphonates. A population-based cohort study [PDF]

open access: yes, 2015
© 2016 Carvajal et al. This is an open access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are ...
Arias, LHM   +7 more
core   +1 more source

Evaluation of Preventive Role of Systemically Applied Erythropoietin after Tooth Extraction in a Bisphosphonate-Induced MRONJ Model

open access: yesMedicina, 2023
Background and Objectives: In this experimental study, the prophylactic effect of systemically administered erythropoietin (EPO) in medication-related osteonecrosis of the jaw (MRONJ) was evaluated.
Gonca Duygu   +4 more
doaj   +1 more source

Biological evaluations of novel 2,3,3-Trisphosphonate in osteoclastic and osteoblastic activities [PDF]

open access: yes, 2017
Bisphosphonates (BPs) are the first line treatment for many bone diseases including hypercalcimia associated with bone malignancies. In this paper, we introduce a new analogue of bisphosphonate called the 2,3,3-Trisphosphonate (2,3,3-TriPP) that was ...
Boccaccini, Aldo R.   +4 more
core   +3 more sources

Cellular and molecular mediators of bone metastatic lesions [PDF]

open access: yes, 2018
Bone is the preferential site of metastasis for breast and prostate tumor. Cancer cells establish a tight relationship with the host tissue, secreting factors that stimulate or inhibit bone cells, receiving signals generated from the bone remodeling ...
Battafarano, Giulia   +3 more
core   +5 more sources

Anti‐Osteoporosis Medications Associated with Decreased Mortality after Hip Fracture

open access: yesOrthopaedic Surgery, 2019
Objective To study the effect of anti‐osteoporosis therapies on mortality after hip fracture. Methods This retrospective study was carried out in the Second Affiliated Hospital of Fujian Medical University and enrolled 690 patients 50 years of age and ...
Pei‐wen Wang   +8 more
doaj   +1 more source

Proximal femoral reconstruction for failed internal fixation of a bisphosphonate-related femur fracture

open access: yesArthroplasty Today, 2016
We present a case of a bisphosphonate-related femur fracture in an elderly woman, who failed treatment with both cephalomedullary nail and proximal femoral locking plate, leading to successful treatment with total hip arthroplasty.
Rishabh G. Jethanandani, BSE   +4 more
doaj   +1 more source

Home - About - Disclaimer - Privacy